Title: Managing Director
Company: Zymo Consulting Group
Location: Newtown Square, Pennsylvania, United States
Kenneth Gorelick, Managing Director at Zymo Consulting Group, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in biotechnology.
As the president and CEO of the Zymo Consulting Group, LLC, Dr. Gorelick provides consulting services to pharmaceutical, biotech, venture capital funds, and contract research organizations. His support aids in the development of new drugs for human use, and he also advises on investments in companies that are developing new drugs or medical devices. His expertise in the health care industry comes from both his legal practice and from hands-on experience in the field. He previously practiced in internal medicine and pulmonary diseases and has worked in a variety of executive roles for health care and pharmaceutical companies. His current work is heavily centered on researching inflammatory bowel diseases and amino-oncology. Dr. Gorelick is a fellow of the American College of Chest Physicians and is involved with the American College of Physicians and the American Medical Association.
Dr. Gorelick began his career by earning a Bachelor of Science in biochemistry from the University at Buffalo in 1973. He continued at Weill Cornell Medicine, receiving an MD in 1978, and he also studied medicine at the University of Paris-Sud. He began working for a small company, but when it went bankrupt he used the hardship to begin consulting while looking for full-time work. Consulting became Dr. Gorelick’s calling, and he found the work more diverse and rewarding. Some of his achievements include holding patents in the method of treating patients.
Early in his career, Dr. Gorelick worked as an associate medical director with Fisons PLC and then as a Director of Clinical Research at XOMA. From 1991 to 1996, he served as the Vice President of Genelabs Technologies, Inc., followed by working as the Vice President of Global Clinical Research & Development position at DuPont. From 1998 to 2000, Dr. Gorelick provided his services as the Chief Managing Officer and Senior Vice President of Pharma Print Inc. He consulted for Wyeth Research for a number of years and was CEO of Enzybiotics Inc. from 2002 to 2009. Since 2004, Dr. Gorelick has been a Venture Partner at NGN Capital LLC. He became Managing Director of Zymo Consulting Group in 2010 and Chief Medical Officer of PIN Pharma, Inc. in 2012. In 2016, he added the role of Director for Neurotrope to his body of work.
Contact Dr. Gorelick